Log In
Print
BCIQ
Print
Print this Print this
 

Vycavert, hydrocodone bitartrate/APAP

  Manage Alerts
Collapse Summary General Information
Company Acura Pharmaceuticals Inc.
DescriptionOral immediate release hydrocodone tablets with acetaminophen using Aversion abuse-deterrent technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat moderate to severe pain
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today